Yin Peng, Wang Haidong, Vos Theo, Li Yichong, Liu Shiwei, Liu Yunning, Liu Jiangmei, Wang Lijun, Naghavi Mohsen, Murray Christopher J L, Zhou Maigeng
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA.
Chest. 2016 Dec;150(6):1269-1280. doi: 10.1016/j.chest.2016.08.1474. Epub 2016 Sep 29.
The trends of COPD mortality and prevalence over the past 2 decades across all provinces remain unknown in China. We used data from the Global Burden of Disease Study 2013 (GBD 2013) to estimate the mortality and prevalence of COPD during 1990 to 2013 at a provincial level.
Following the general analytic strategy used in GBD 2013, we analyzed the age- sex- and province-specific mortality and prevalence of COPD in China. Levels of and trends in COPD mortality and prevalence were assessed for 33 province-level administrative units during 1990 to 2013.
In 2013, there were 910,809 deaths from COPD in China, accounting for 31.1% of the total deaths from COPD in the world. From 1990 to 2013, the age-standardized COPD mortality rate decreased in all provinces, with the highest reduction in Heilongjiang (70.2%) and Jilin (70.0%) and the lowest reduction in Guizhou (26.8%). In 2013, the death rate per 100,000 was highest in Guizhou (196.0) and lowest in Tianjin (34.0) among men and highest in Gansu (141.1) and lowest in Beijing (23.7) among women. The number of COPD cases increased dramatically from 32.4 million in 1990 to 54.8 million in 2013. The age-standardized prevalence rate of COPD remained stable overall and varied little for all provinces.
COPD remains a huge health burden in many western provinces in China. The substantial increase in COPD cases represents an ongoing challenge given the rapidly aging Chinese population. A targeted control and prevention strategy should be developed at a provincial level to reduce the burden caused by COPD.
过去20年中国各省慢性阻塞性肺疾病（COPD）的死亡率和患病率趋势仍不清楚。我们利用2013年全球疾病负担研究（GBD 2013）的数据，在省级层面估算1990年至2013年期间COPD的死亡率和患病率。
遵循GBD 2013中使用的一般分析策略，我们分析了中国COPD的年龄、性别和省份特异性死亡率及患病率。评估了1990年至2013年期间33个省级行政区COPD死亡率和患病率的水平及趋势。
2013年，中国有910,809例死于COPD，占全球COPD死亡总数的31.1%。1990年至2013年，所有省份的年龄标准化COPD死亡率均下降，黑龙江（70.2%）和吉林（70.0%）降幅最大，贵州（26.8%）降幅最小。2013年，男性中每10万人死亡率最高的是贵州（196.0），最低的是天津（34.0）；女性中每10万人死亡率最高的是甘肃（141.1），最低的是北京（23.7）。COPD病例数从1990年的3240万急剧增加到2013年的5480万。COPD的年龄标准化患病率总体保持稳定，各省差异不大。
在中国许多西部省份，COPD仍然是一个巨大的健康负担。鉴于中国人口迅速老龄化，COPD病例的大幅增加是一个持续挑战。应在省级层面制定有针对性的控制和预防策略，以减轻COPD造成的负担。
